Table 3.
The number of patients in each SOFA score category before and after propensity score matching
| SOFA score | Unmatched groups | Matched groups | ||||
|---|---|---|---|---|---|---|
| PMX (n = 2191) |
Control (n = 41,986) | ASD (%) | PMX (n = 2033) |
Control (n = 2033) |
ASD (%) | |
| 0–6 | 483 (22.0) | 27,006 (64.3) | 75.3 | 456 (22.4) | 407 (20.0) | 4.8 |
| 7–9 | 580 (26.5) | 7729 (18.4) | 16.2 | 553 (27.2) | 463 (22.8) | 8.4 |
| 10–12 | 551 (25.1) | 4499 (10.7) | 33.1 | 510 (25.1) | 529 (26.0) | 1.7 |
| 13–15 | 399 (18.2) | 1991 (4.7) | 38.9 | 356 (17.5) | 404 (19.9) | 4.9 |
| 16–24 | 178 (8.1) | 761 (1.8) | 26.9 | 158 (7.8) | 230 (11.3) | 9.6 |
SOFA Sequential Organ Failure Assessment, ASD absolute standard difference